tfx06

ER+, HER2- Advanced Breast Cancer

Zhejiang Yangli Pharmaceutical Technology Co., Ltd.Phase 1/2

—

Rating in progress

tfx06 in ER+, HER2- Advanced Breast Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active